Evidence from investigations with DPP-4 inhibitors in diabetic eNOS knockout mice (Alter et al., 2012), a model of diabetic nephropathy, suggests the potential of DPP-4 inhibitors to reduce albumin excretion. This evidence concerns the gene DPP4 and diabetic kidney disease.